T ransduction of the Escherichia coli cytosine deaminase (CD ) gene into tumor cells followed by administration of 5-fluorocytosine (5 -FC ), deemed 5 -FC / CD gene therapy, was created as a suicide gene therapy for various cancers. The uracil phosphoribosyltransferase (UPRT ) gene, which is absent from mammalian cells, directly converts 5 -fluorouracil (5 -FU ) to 5-fluorouridine 5 0 -monophosphate. 1, 2 We previously demonstrated that coexpression of CD and UPRT genes generated a cooperative antitumor effect on experimental brain tumors. 2 Radiation therapy has been commonly employed in glioma patients; moreover, it has enhanced the efficacy of chemotherapy, resulting in significant prolongation of patient survival. The present study investigated the ability of radiation therapy to enhance CD plus UPRT gene therapy for brain tumors. Additionally, we examined the untoward effects of this combined modality on normal brain.
Materials and methods

Cell line and adenovirus vectors
Rat 9 L gliosarcoma cells were grown in Eagle's minimum essential medium ( Gibco BRL, Grand Island, NY ) supplemented with 10% fetal bovine serum (Gibco BRL, Grand Island, NY ) and antibiotics ( 40 U /mL penicillin G and 100 g /mL streptomycin ). Three recombinant replicationdeficient adenovirus vectors, AdCA -LacZ, AdCA -CD, and AdCA -UPRT, were constructed from a serotype 5 wild -type adenovirus ( Ad5 ) through insertion of a CAG promoter with E. coli LacZ gene, E. coli CD gene and E. coli UPRT gene, respectively, into the E1A region of the genome. The E1B and E3 regions were deleted. Viral titers were determined by end -point cytopathic effect assay on 293 cells and expressed as plaque -forming units ( pfu ) per milliliter.
Chemoradiosensitivity
At room temperature, exponentially growing cells in 96 -well plates were exposed to X -ray at a dose rate of 1.5 Gy /min employing an irradiation apparatus ( MBR -1520A -TW; Hitachi Medico, Tokyo, Japan ). Radiation sensitivity of 9 L cells was assessed by measuring conversion of the tetrazolium salt, 3 -( 4,5-dimethylthiazol -2 -yl ) -2,5 -diphenyltetrazolium bromide (MTT ) ( Sigma, St. Louis, MO ), to formazan. Results were expressed as a growth ratio compared with the control. Additionally, the combined antitumor effect of 5-FC /CD +UPRT therapy and radiation was investigated in vitro. Cells were seeded in 96 -well plates at a density of 1000 cells/well. Seeded cells were subsequently infected with virus on day 0, exposed to 5 -FC on day 1, and irradiated on day 2. Six days later, sensitivity was assessed by MTT assay.
Flow cytometric analysis of apoptosis
Cells were seeded in 6 -cm dish at a density of 5Â10 4 cells. Seeded cells were subsequently infected with virus at total multiplicity of infection (MOI) of 50 on day 0, exposed to 5 -FC at a concentration of 10 M on day 1, and irradiated ( 10 Gy ) on day 2. Then we collected the cells on day 5. Apoptosis of treated tumor cells was detected using the APO -BRDU kit ( Pharmingen, San Diego, CA ), according to the manufacturer's instructions. Briefly, the 3 0 -hydroxyl ends of the DNA in apoptotic cells were labeled with bromolated deoxyuridine triphosphate nucleotides ( Br-dUTP ) by terminal deoxynucleotidyl transferase, and the incorporated BrdU was stained with a fluorescein isothiocyanate ( FITC )-labeled anti -BrdU monoclonal antibody. After DNA was stained with propidium iodide, the cells were analyzed by FACScan.
In vivo antitumor activity
An approved rat brain tumor model was employed to evaluate the therapeutic efficacy of the combination of 5 -FC / CD + UPRT gene therapy and external irradiation. All experimental animals were housed and handled in accordance with the Okayama University Animal Research Committee guidelines. Male Wistar rats ( Charles River Laboratory, Osaka, Japan ), weighing 250-300 g each, were used for animal experiments. In order to establish brain tumors, rats were anesthesized with intraperitoneal ( i.p. ) Nembutal ( 30 mg /kg ) and placed on a stereotactic apparatus ( Narishige, Tokyo, Japan ). As described previously, 1 -3 9 L cells (1Â10 5 cells / 5 L ) were slowly injected into the basal ganglia of the right cerebral hemisphere ( 4 mm lateral to the midline, 2 mm posterior to the coronal suture, 5 mm depth from the dura ) utilizing Hamilton syringes (Hamilton, Reno, NV ). Four days following tumor inoculation, all rats bearing brain tumors were reanesthesized and subsequently injected with AdCA -CD (5Â10 6 pfu / 5 L ) and AdCA -UPRT ( 5Â10 6 pfu /5 L ) stereotactically at the tumor inoculation site based on the same coordinates.
Beginning on day 2, the rats received i.p. 5-FC at concentration of 500 mg /kg, or saline (control ) once per day for 2 weeks. On day 12, the rats were reanesthesized and subjected to whole brain irradiation to a dose of 15 Gy by using the irradiation apparatus at 1.5 Gy /min with customized shielding that allowed selective administration of radiation to the whole brain. Rats were observed and sacrificed near death. Rat brains were fixed, sliced into 50-m sections, and stained with hematoxylin -eosin ( HE ) and Kluver-Barrera (KB ) stainings for histological evaluation.
Results
Chemoradiosensitivity
In vitro experiments revealed the radiosensitivity of 9 L cells ( Fig 1) . According to the linear curve of Figure 1 , radiation doses of 10.2 Gy inhibited 50% of control in 9 L cells. Our previous study showed that 9 L cells were successfully transduced by adenovirus harboring LacZ, CD, or UPRT genes. AdCA -LacZ and AdCA -UPRT vectors were not cytotoxic at an MOI of less than 1000, whereas AdCA -CD displayed a relatively strong toxicity, the critical level of which occurred at an MOI of 100.
1 Figure 2 illustrates the effects of combined modality treatments on 9 L cells. 9 L cells were infected with AdCA -CD and AdCA -UPRT following 5 -FC and radiation (5 Gy ) exposure. The cell survival of the CD / 5-FC + radiation group was significantly lower than that of the CD group; moreover, the cell survival of the CD + UPRT /5 -FC + radiation group was significantly lower than that of the CD +UPRT /5 -FC group. In vitro sensitivity to 5 -FC following transduction with AdCA -CD or AdCA -CD and AdCA -UPRT and irradiation. Cells were seeded in 96 -well plates at a density of 1000 cells / well. Cells were subsequently infected with virus on day 0, exposed to 5 -FC on day 1, and irradiated on day 2. Six days later, sensitivity was assessed by MTT assay. At 12.5 M 5 -FC, percent of control differed significantly in the four treatment groups ( P < .01 ). Values were 65.71 ± 6.24%, 53.71 ± 3.8%, 43.27 ± 3.0%, and 33.43 ± 2.8% in the CD, CD + radiation, CD + UPRT, and CD + UPRT + radiation groups, respectively.
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CD+UPRT gene therapy and radiation for gliomas H Kambara et al Concentrations of 5 -FC inhibiting 50% of control were 34, 23, 3.6, and 1.8 M in the CD, CD +radiation, CD +UPRT, and CD + UPRT +radiation groups, respectively. At 12.5 M 5 -FC, percent of control in the MTT assay differed significantly in the four treatment groups (P < .01). Values were 65.71 ± 6.24%, 53.71 ± 3.8%, 43.27 ± 3.0%, and 33.43 ± 2.8% in the CD, CD + radiation, CD + UPRT, and CD +UPRT + radiation groups, respectively (Fig 2) . Synergistic cytotoxicity is commonly defined as cytotoxicity of greater magnitude with simultaneously delivered treatments relative to the summed cytotoxic effects of single treatments. Strict synergistic interaction between CD +UPRT infection plus 5 -FC and radiation treatments was not observed in this experimental model. However, a significant cytotoxic interaction of these treatments was indicated by the results.
Induction of apoptosis with CD plus UPRT gene therapy and radiation
From the results of chemoradiosensitivity assays, we considered that radiation had an enhancing effect on induction of apoptosis by CD plus UPRT gene therapy. Treated 9 L cells with CD plus UPRT gene therapy only, or in combination with radiation, were investigated by flow cytometric analysis using the APO -BRDU kit. The results are shown in Figure 3 . Treatment with CD gene therapy induced apoptosis in 21% cells ( Fig 3C ) , combined therapy (CD gene therapy and radiation ) induced apoptosis in 60% ( Fig 3D ) , CD plus UPRT gene therapy induced apoptosis in 41% (Fig 3E ) , and combined therapy (CD plus UPRT gene therapy and radiation ) induced apoptosis in 73% (Fig 3F ) . The results indicated that a positive cytotoxic interaction of CD plus UPRT gene therapy and radiation was mainly or partly caused by apoptotic mechanism and suggested that the combination of gene therapy and radiation could induce apoptosis synergistically.
In vivo antitumor activity
In vivo antitumor effects of the combined treatments of gene therapy and radiation were analyzed using a 9 L brain tumor model. Survival analysis was conducted for 90 days following tumor inoculation. The median survival time ( MST ) of the control group ( saline i.p. injection exclusively, no radiation ) ( n= 10 ) and the saline with radiation group ( n =9 ) was 38 and 40 days ( Fig 4 ) , respectively. All rats in these groups died within 62 days following tumor inoculation. Rats surviving for greater than 90 days included 3 of 10 animals in the 5 -FC ( 500 mg /kg ) without radiation group (n =10 ) and 7 of 10 animals in the 5 -FC ( 500 mg / kg) with radiation group (n = 10). The CD + UPRT /5-FC group and the CD + UPRT /5-FC with radiation group had significantly longer ( P< .01 ) survival than rats in other groups ( CD + UPRT /saline, CD +UPRT /saline with radiation ). In addition, the survival time of the CD +UPRT /5 -FC with radiation group was significantly longer (P=.0471) than the CD + UPRT/ 5-FC group (Fig 4) . pfu / 5 L ) were injected followed by i.p. administration of 5 -FC ( 500 mg / kg ) or saline once daily for 14 days. The rats were reanesthesized and subjected to whole brain irradiation consisting of a total dose of 15 Gy. The rats were followed until 90 days following tumor inoculation. The CD + UPRT / 5 -FC group and the CD + UPRT / 5 -FC with radiation group had significantly longer ( P < .01 ) survival than rats in other groups ( CD + UPRT / saline, CD + UPRT / saline with radiation ). In addition, the survival time of the CD + UPRT / 5 -FC with radiation group was significantly 
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For the histological evaluation of the combined therapy, 12 additional rats were divided into three groups: CD + UPRT without 5-FC, 5-FC /CD +UPRT with radiation, and 5 -FC / CD + UPRT without radiation. Treatment was identical to the aforementioned protocol. Animals were sacrificed on day 20. Presence of 9 L tumor and brain damage were examined in all sliced sections of resected brains. HE staining showed huge 9 L tumors in all rats in the CD + UPRT without 5-FC group (Fig 5A ) , and small 9 L tumors in all rats in the 5-FC /CD +UPRT without radiation group ( Fig 5B ) . In the 5 -FC /CD +UPRT with radiation group, 9 L tumors were not apparent in all rats; however, focal brain damage was recognized, including necrotic change and surrounding demyelination, at the injection site of the basal 
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Long -surviving rats of 5 -FC /CD + UPRT with radiation group exhibited no abnormal general findings in comparison to normal rats. Surviving rats were sacrificed and their brains were subjected to histological analysis. HE staining demonstrated the absence of tumor cells at the injection sites; moreover, necrotic tissues surrounded by inflammatory cells ( macrophages, lymphocytes, and plasma cells ) were revealed (Fig 6A ) . KB staining clearly showed demyelination in the white matter around basal ganglia at the injection side ( Fig 6, B and C) . On the contrary, no demyelination was observed in the white matter at the contralateral side ( Fig 6D ) . Several samples displayed brain atrophy and enlargement of ventricles in not only the vector -injected side but also whole brains.
Discussion
The primary limitations of systemic chemotherapy are a low local concentration of the therapeutic agent and systemic side effects. In order to overcome this problem, a prodrug/ enzyme system possesses the theoretical advantage of delivering high local concentrations of a therapeutic agent while minimizing systemic side effects, thus increasing the therapeutic window. The first trial employing the 5 -FC /CD system for malignancy was described in 1985. 4 This gene therapy utilizing adenovirus vectors has been applied to several types of solid tumors, including colorectal, 5, 6 gastric, 7 and hepatocellular cancers, 8 as well as gliomas. 1, 9 Transduction of the UPRT gene has been reported to enhance chemosensitivity to 5 -FU or 5 -FC through the activation pathway to 5-FU. 10 Simultaneous expression of CD and UPRT generated a cooperative effect, dramatically increasing the 5 -FC sensitivity of cells compared to the expression of CD alone. 2, 11 Furthermore, the association of UPRT with CD facilitated uptake of 5 -FC when the drug penetrates cells through passive diffusion as in mammalian cells by direct channeling of 5 -FU to 5 -FUMP. 11 In a previous report, we also documented that UPRTtransduced 9 L cells were 16 times more sensitive to 5 -FU, whereas CD plus UPRT-transduced cells were 6000 times more sensitive to 5-FC than the parent 9 L cells. 2 In 5 -FC / CD +UPRT gene therapy, only 1% transduction of 9 L cells with AdCA -CD and AdCA -UPRT affected cell growth; moreover, a maximal tumoricidal effect was seen when only 5 -10% of the tumor cells were transduced with the genes. 2 This finding implied that 5-FC /CD +UPRT gene therapy affords a strong bystander effect, promising in vivo efficacy of gene therapy. In the brain tumor model, we obtained higher efficacy of 5 -FC /CD + UPRT gene therapy in comparison to the 5-FC /CD gene therapy. 2 The roles for radiation therapy in the treatment of malignancy have involved utility as a single or multiple agents. However, radiation therapy is more commonly employed in an adjuvant or neo -adjuvant manner. To date, radiation therapy for gliomas is an established modality that permits patients' survival advantage. Hence, the multimodality approach including radiation therapy is a common strategy for gliomas. Some reports have shown the advantage of additional radiation therapy to gene therapy, such as p53 gene 12, 13 and ganciclovir (GCV ) /herpes simplex virus thymidine kinase ( HSV-TK ) prodrug /enzyme therapies. 14 -18 Additionally, combined therapy with 5-FC /CD treatment plus radiation was reported to have a therapeutic advantage compared to 5-FC /CD therapy alone. 5,16,19 -21 Khil et al 21 demonstrated that the CD gene, upon stable transfection into WiDr cells, was able to enhance radiation cell killing. Pederson et al 20 reported the usefulness of 5 -FC /CD therapy combined with radiation therapy for cholangiocarcinoma cells in vitro and in vivo. Ohwada et al 5 documented the utility of colon carcinoma xenografts. These reports indicated a positive cytotoxic interaction of 5-FC / CD therapy and radiation; however, to our knowledge, no studies exist regarding the combination of 5 -FC / CD + UPRT gene therapy and radiation. Our in vitro study suggested evidence of a significant positive cytotoxic interaction between radiation therapy and 5 -FC / CD + UPRT gene therapy for glioma cells. In addition, flow cytometric analysis of apoptosis indicated that the cytotoxic effect was synergistic. Our in vivo experiments showed that 5-FC / CD + UPRT plus radiation therapy provided a significant longer survival of rats than 5 -FC /CD + UPRT therapy alone. This finding indicated that radiation therapy demonstrated an additional survival effect on rats harboring brain tumors. We attempted to reduce the administration dose of 5-FC; however, doses of less than 500 mg /kg 5-FC did not have an effect on the survival of experimental rats (data not shown ). Previous investigations involving 5-FC /CD also employed 500 mg /kg (or more ) 5 -FC as the administration dose for animals.
Neurotoxicity of prodrug/ enzyme systems is a critical problem in clinical trials. Goodman et al 22 reported the toxicity of adenovirus -mediated GCV / HSV-TK gene therapy on infection in the brain of a baboon. Injection of high doses (1.5Â10 9 pfu ) of adenovirus caused animal death within a few days following GCV treatment. Coagulative necrosis, edema, and perivascular lymphocytosis were observed with intensive treatment. Smith et al 23 also noted local toxicity of the same system in rat brains. In our previous study, necrosis, demyelination, and gliosis were recognized in 5 -FC / CD gene therapy for brain tumors. 1 In order to relieve neurotoxicity in the current investigation, 5 -FC administration dosages were reduced, resulting in failure as stated above. Although the combination of 5-FC /CD gene therapy and radiation demonstrated superior antitumor effect relative to 5 -FC /CD gene therapy alone, neurotoxicity was present in brain tissues in our histological examination. The characteristic neurotoxicities observed in this investigation, brain atrophy and ventricular enlargement, were not focal damage at the tumor sites, but global and diffuse brain damage primarily attributable to radiation therapy. These neurotoxicities were not evident in early stage disease, but were clarified in late stage following treatment. Recently, stereotactic radiosurgery or radiotherapy can be applied for brain tumors to avoid the neurotoxicities of whole brain irradiation.
According to previous reports concerning gene therapy in concert with radiation, radiation dosages consisting mainly of 15 -20 Gy were delivered in rat brain tumor models. 12, 17 Histological analysis of longitudinally surviving rats was not documented. Consequently, we were unable to compare brain alterations to the Kim and Broaddus data. Global brain damages observed in the current investigation were difficult to recognize symptomatically in rodents; however, these are important issues related to memory or cognitive functions in human patients. In order to prevent this type of damage, radiation field and dose should be considered in combination therapy.
In summary, we reported that the combination of 5 -FC / CD +UPRT gene therapy and radiation displayed remarkable antitumor effect on gliomas. We should consider the adverse effects of radiation in combination with gene therapy for normal brain.
